ARTICLE | Company News
Crucell management update
January 22, 2002 8:00 AM UTC
Crucell N.V. (Euronext:CRXL; CRXL), Leiden, the Netherlands Business: Cancer Appointed: Stef Heylen as VP of development and regulatory affairs, formerly VP of medical affairs for Europe, the Middle-E...